Delivery Order SPE2DB22D3301-SPE2DB25FY2LK

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,023.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Armour Thyroid 30 mg Tablets in 100-count packages. The award has a ceiling value of $1,023.83 and an ultimate completion date of February 27, 2025. This contract is not designated as a set-aside and is an open competition award....
The federal government awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Armour Thyroid 60 mg tablets. The $1,604.96 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of January 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen, a for-profit organization, maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,295.49, is for the delivery of Armour Thyroid 90 mg tablets. It is a firm fixed-price delivery order contract with a period of performance ending on May 9, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,120.35 Firm Fixed Price Delivery Order contract is for the supply of 4560956815 - Armour Thyroid 60 mg tablets in 100-count packages. The contract has a performance period through May 17, 2023 and was awarded on May 16, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,462.88 firm fixed-price delivery order covers the supply of Armour Thyroid 30 mg tablets for a period ending on July 23, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.75 firm fixed-price delivery order is for the supply of Armour Thyroid 90 mg tablets. The contract has an ultimate completion date of January 9, 2024 and was awarded on January 8, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,466.11, is for the delivery of Armour Thyroid 30 mg tablets. This is a firm fixed-price delivery order contract, with an ultimate completion date of October 23, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $11,533.65 firm fixed-price delivery order contract is for the provision of 4,567,202,256 units of Armour Thyroid 90 mg tablets, with a performance period ending on February 10, 2025. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,436.17, is for the delivery of Armour Thyroid 60 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of December 6, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of Armour Thyroid 90 mg tablets. The $1,098.60 firm fixed-price delivery order contract has an ultimate completion date of February 12, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC serves as a vehicle...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY2LK
    Delivery Order

This federal contract award, with the ID SPE2DB22D3301|SPE2DB25FY2LK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Armour Thyroid 90 mg tablets in 100-count bottles, with a ceiling value of $1,872.50 and a completion date of April 1, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any major subcontractors. This contract supports the DLA's mission of providing pharmaceutical and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 6/30/25, 10:53 AM